subject area of
- A Multicenter Phase II Clinical Trial of Lapatinib (GW572016) in Hormonally Untreated Advanced Prostate Cancer Journal Articles
- Dual-Agent Molecular Targeting of the ErbB2 Receptor: Killing One Bird With Two Stones Journal Articles
- Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib Journal Articles
- Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31 Journal Articles
- Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial Journal Articles
- Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands Journal Articles